Leap Therapeutics Reports First Quarter 2022 Financial Results
/PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported...
Source: prnewswire.com
Page 23 - Poster Presentation News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Poster Presentation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Poster Presentation Today - Breaking & Trending Today
Astellas Highlights Data on Advanced and Rare Cancers during 2022 ASCO Annual Meeting and EHA 2022 Hybrid Congress
/PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") will share new research during the 2022 American Society...
Source: prnewswire.com
Merck To Present Data at 2022 ASCO Annual Meeting Highlighting Promising Pipeline Medicines and Significant Progress in Treating Earlier Stages of Certain Cancers With KEYTRUDA (pembrolizumab)
10.05.2022 - Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that data for six approved medicines and pipeline candidates in more than 25 types of cancer will be presented at the 2022 American Society of Clinical Oncology ...
Source: wallstreet-online.de
Gamida Cell Ltd. (GMDA) Management on Q1 2022 Results - Earnings Call Transcript
Gamida Cell Ltd. (NASDAQ:NASDAQ:GMDA) Q1 2022 Results Conference Call May 10, 2022 08:00 AM ET Company Participants Heather DiVecchia - Chief of Staff Michele Korfin - Chief Operating...
Source: seekingalpha.com
Iterion Therapeutics Announces Presentation of Three Posters Involving Research into Tegavivint at the AACR 2022 Annual Meeting
/PRNewswire/ -- Iterion Therapeutics, Inc., a venture-backed, clinical-stage biotechnology company developing novel cancer therapeutics, today announced that...
Source: prnewswire.com